Expert Interview
Discussing the potential of Axsome's drug AXS-14 (esreboxetine) for the treatment of Fibromyalgia.
Ticker(s): AXSMInstitution: Weill Cornell Medicine
- Medical Director of Pain Medicine at the Weill-Cornell Pain Medicine Center, and New York Presbyterian Hospital, Co-Director, Weill Cornell Mutli-Disciplinary Spine Center, & Associate Program Director of the Tri-Institutional Interventional Pain Medicine.
- Treats roughly 350 patients with post operative pain per month.
- Clinical interests lie in the minimally invasive procedures to treat musculoskeletal pain, including various types of injections, intrathecal pump therapy, Spinal Cord Stimulation, and the MILD© Procedure for Spinal Stenosis.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
